73 related articles for article (PubMed ID: 19307991)
1. CD40-activated apoptotic tumor cell-pulsed dendritic cell could potentially elicit antitumor immune response: involvement of up-regulation of B7-H3 expression.
Chen C; Zhu YB; Qu QX; Ge Y; Huang JA; Wang Y; Zhang XG
J Immunother; 2009 Jan; 32(1):29-35. PubMed ID: 19307991
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
3. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
4. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
5. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of B7-H4 in tumor infiltrated dendritic cells.
Cheng C; Qu QX; Shen Y; Lv YT; Zhu YB; Zhang XG; Huang JA
J Immunoassay Immunochem; 2011; 32(4):353-64. PubMed ID: 21728826
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
Ranheim EA; Kipps TJ
Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis.
Clayton AR; Prue RL; Harper L; Drayson MT; Savage CO
Arthritis Rheum; 2003 Aug; 48(8):2362-74. PubMed ID: 12905492
[TBL] [Abstract][Full Text] [Related]
9. The expression analysis of ICOS-L on activated T cells and immature dendritic cells as well as malignant B cells and Grave's-disease-derived thyroid tissues by two novel mAbs against human ICOS-L.
Wang F; Zhu W; Liu T; Sun Z; Ju S; Ju S; Yu G; Xie W; Deng Z; Lu B; Zhang X
Tissue Antigens; 2007 Jan; 69(1):62-72. PubMed ID: 17212709
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo stimulation of murine dendritic cells by an exopolysaccharide from one of the anamorph of Cordyceps sinensis.
Song D; Lin J; Yuan F; Zhang W
Cell Biochem Funct; 2011 Oct; 29(7):555-61. PubMed ID: 21755524
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
12. Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets.
Balkhi MY; Latchumanan VK; Singh B; Sharma P; Natarajan K
J Leukoc Biol; 2004 May; 75(5):874-83. PubMed ID: 14966193
[TBL] [Abstract][Full Text] [Related]
13. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
Aicher A; Shu GL; Magaletti D; Mulvania T; Pezzutto A; Craxton A; Clark EA
J Immunol; 1999 Dec; 163(11):5786-95. PubMed ID: 10570261
[TBL] [Abstract][Full Text] [Related]
14. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
Jones KW; Hackett CJ
Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
[TBL] [Abstract][Full Text] [Related]
15. CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro.
Haase C; Michelsen BK; Jørgensen TN
Scand J Immunol; 2004 Mar; 59(3):237-45. PubMed ID: 15030573
[TBL] [Abstract][Full Text] [Related]
16. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
Mejri N; Gottstein B
Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
[TBL] [Abstract][Full Text] [Related]
18. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
Grünebach F; Kayser K; Weck MM; Müller MR; Appel S; Brossart P
Cancer Gene Ther; 2005 Sep; 12(9):749-56. PubMed ID: 15877082
[TBL] [Abstract][Full Text] [Related]
19. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
[TBL] [Abstract][Full Text] [Related]
20. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
